Allergan Settles Kickback Scheme Suit

Jul 05, 2017

Philly.com

Allergan has agreed to pay $13 million to settle a whistle-blower lawsuit brought by two Philadelphia-area ophthalmologists who alleged that the drugmaker engaged in a kickback scheme in order to get physicians to prescribe its eye-care medications.

Ophthalmologists Herbert Nevyas and Anita Nevyas-Wallace said that Allergan offered paid speaking engagements, free business consulting, and other services in order to stimulate sales of eye-care drugs Restasis and Acular.

Allergan agreed to pay $13 million to settle the case. The funds will be shared by Nevyas and Nevyas-Wallace, the federal government, and 19 states involved in the action.

Read the Philly.com article